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ABSTRACT
Hepatic artery thrombosis is a concerning complication of orthotopic liver transplantation, and it most often
occurs early in the posttransplant period. However, on rare occasions it can occur at a time remote from trans-
plant. We present a case of ischemic cholangiopathy complicated by stricture and anastomotic bile leak from
chronic hepatic artery thrombosis that occurred 11 years after the transplant. The initial biliary stenting helped
with the resolution of the leak but she was found to have stones, sludge and copious pus at the time of stent
exchange. Hepatic arteriography demonstrated complete occlusion of the transplant hepatic artery with peripor-
tal collaterals reconstituting intrahepatic hepatic arterial branches. The patient was subsequently referred for
repeat liver transplantation.
INTRODUCTION
Orthotopic liver transplantation has become the standard of care for acute and chronic liver failure. While advan-
ces in both surgical and medical modalities continue to improve outcomes, both short- and long-term complica-
tions can occur. One of the most concerning complications is hepatic artery thrombosis (HAT), which is the most
common complication necessitating repeat transplanation.1 HAT is of greatest concern in the immediate transplant
setting because it often presents with ischemia and necrosis. Early and late HAT are differentiated by a cutoff of 21
days.2 Late HAT is less clinically conspicuous although still serious, most often presenting with biliary pathology
with a median time to presenation of 4–6 months after transplant.3-5 Over time, the incidence of HAT decreases,
rarely occuring more than 5 years after transplant. However, patients remain at risk for the lifetime of the graft.
CASE REPORT
A 54-year-old woman with a history of well-controlled diabetes mellitus, tobacco abuse, and autoimmune hepatitis
status post orthotopic liver transplant (OLT) 11 years prior was found on routine follow-up to have asymptomatic
elevation in her liver tests: alkaline phosphatase 313 U/L (normal 25–125 U/L), alanine aminotransferase 92 U/L (nor-
mal 7–52 U/L), and total bilirubin 2.7 mg/dL (normal 0–1.0 mg/dL). Her posttransplant course had previosuly been
benign outside of recurrent autoimmune hepatitis 8 years prior, which responded to steroids. No changes were
made to her immunosuppressive regimen. She denied recent illnesses, alcohol, or illicit drugs, and she reported
compliance with her medications. Evaluation with magnetic resonance cholangiopancreatography revealed severe
donor-duct biliary dilation, anastomotic stricture, and periductal cystic changes with normal recipient common
duct and pancreatic duct caliber (Figure 1). Endoscopic retrograde cholangiopancreatography (ERCP) revealed a
moderate biliary stricture at the posttransplant anastamosis, with marked dilation of the donor biliary tree and
anastomotic bile leak concerning for ischemic cholangiopathy. No stones were noted, but they were not
ACG Case Rep J 2018;5:e75. doi:10.14309/crj.2018.75. Published online: October 24, 2018.
Correspondence: Raj Vuppalanchi, MBBS, Associate Professor of Medicine, Division of Gastroenterology Indiana University School of Medicine, 702 Rotary
Circle, Suite 225, Indianapolis, IN 46202 (rvuppala@iu.edu).
Copyright: © 2018 Krajicek et al. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.
ACG Case Reports Journal / Volume 5 acgcasereports.gi.org 1
ACGCASE REPORTS JOURNAL
speciﬁcally addressed in view of the leak. An 8.5-Fr biliary
stent was placed into the donor duct with a repeat ERCP
planned at 2 months follow-up. Computed tomography with
contrast was negative for biloma or mass, but visualization of
the hepatic artery was poor. The patient was monitored over-
night and discharged with signiﬁcant clinical improvement.
Six weeks later she presented with complaints of malaise,
nausea, and anorexia, but her evaluation showed normal liver
tests and minimally impaired synthetic function (international
normalized ratio 1.38). Repeat ERCP for stent exchange
showed severe dilation of the donor ducts with stones,
sludge, and copius pus (Figure 2). The leak had resolved. This
raised concern for the integrity of the hepatic artery and is-
chemic cholangiopathy. Hepatic arteriography demonstrated
complete occlusion of the transplant hepatic artery with peri-
portal collaterals reconstituting intrahepatic hepatic arterial
branches (Figure 3). The presence of collateral circulation
and the patient’s asymptomatic clinical presentation sug-
gested that she had developed chronic hepatic artery throm-
bosis (HAT) at a time remote from transplantation, which led
to chronic ischemic cholangiopathy and bile duct disruption
with a leak. Interventional radiology did not feel the lesion
was amenable to intravascular intervention. After discussion
with Transplant Surgery, evaluation for repeat transplantation
was deemed the most appropriate course of action.
DISCUSSION
This case represents rare timing of a dangerous complication
of OLT with classic clinical, radiographic, and endoscopic
ﬁndings. HAT can be seen in up to 9% of OLT patients,2 and
while acute HAT is concerning due to its dramatic presenta-
tion, late HAT has its own serious consequences. Given the
necessary severing of natural capsular collaterals with OLT,
the biliary tree is dependent on the hepatic artery, leading to
Figure 1. Magnetic resonance cholangiopancreatography image showing
a normal-caliber common bile duct, a pancreatic duct with stricture, and
massive intrahepatic biliary duct dilation.
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Figure 2. (A) Fluoroscopic image of cholangiogram with biliary stricture
and stones. (B) Endoscopic image of pus and sludge draining from com-
mon bile duct stent.
Figure 3. Angiographic image of the celiac artery showing the abrupt termination of common hepatic artery with signiﬁcant collateralization arising
from the gastroduodenal artery.
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the risk of ischemic cholangiopathy with hepatic artery com-
promise. Smoking and diabetes, as seen in this case, may
increase the risk for HAT, but the underlying cause is often
unclear. This ischemia leads to biliary strictures, leaks, sludge,
stones, and bile duct casts, all of which can be complicated by
recurrent cholangitis.6 Nonsurgical approaches to manage-
ment, including percutaneous stricture dilation, stenting, and
repeat therapeutic ERCP, have become the standard of care
in these patients. However, patients who have failed these
therapies or who present with recurrent cholangitis require
repeat transplantation.7,8 This case is instructive with
regard to both basic hepatic vascular and biliary anatomy
and the need for adequate understanding of clinical hepa-
tology, transplant hepatology, and advanced endoscopy.
Furthermore, it is imperative for the general gastroenterol-
ogist to recognize this entity because medical advances
have led to longer complication-free posttransplant survival
times. As a result, more of these patients will return to the
general gastroenterology practice for longitudinal care.
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